Evogene Ltd.

NASDAQ: EVGN · Real-Time Price · USD
1.22
0.03 (2.92%)
At close: May 23, 2025, 3:59 PM
1.17
-4.06%
After-hours: May 23, 2025, 05:56 PM EDT
2.92%
Bid 1.17
Market Cap 8.14M
Revenue (ttm) 8.51M
Net Income (ttm) -16.48M
EPS (ttm) -2.89
PE Ratio (ttm) -0.42
Forward PE -0.87
Analyst Buy
Ask 1.34
Volume 15,095
Avg. Volume (20D) 372,557
Open 1.20
Previous Close 1.19
Day's Range 1.14 - 1.22
52-Week Range 0.95 - 8.50
Beta 1.55

About EVGN

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol EVGN
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for EVGN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

Evogene has released their quartely earnings on May 21, 2025:
  • Revenue of $2.44M misses estimates by $1.98M, with -41.67% YoY decline.
  • EPS of -0.38 exceeds estimates by 0.12, with 50.00% YoY growth.
  • 1 month ago
    +30.93%
    Evogene shares are trading higher after the compan... Unlock content with Pro Subscription
    7 months ago
    +19.92%
    Evogene shares are trading higher after the company announced its subsidiary received a grant from the Israel Innovation Authority to advance its program to develop a technology for the delivery of Ag-biologicals to agriculture.